Bjoern Jensen, Nadine Luebke, Torsten Feldt, Verena Keitel, Timo Brandenburger, Detlef Kindgen-Milles, . . . Tom Luedde. (2021). Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Elsevier.
Chicago Style (17th ed.) CitationBjoern Jensen, et al. Emergence of the E484K Mutation in SARS-COV-2-infected Immunocompromised Patients Treated with Bamlanivimab in Germany. Elsevier, 2021.
MLA (9th ed.) CitationBjoern Jensen, et al. Emergence of the E484K Mutation in SARS-COV-2-infected Immunocompromised Patients Treated with Bamlanivimab in Germany. Elsevier, 2021.
Warning: These citations may not always be 100% accurate.